Quatrefolic® and MenaQ7® Set New Standards in Australian Nutritional Innovation

Share this article:

Quatrefolic® and MenaQ7® Set New Standards in Australian Nutritional Innovation
On May 7th, Complementary Medicines Australia (CMA) hosted their Innovation Day, and we were proud to see our key ingredients, Vitamin K2 (MenaQ7®) and Active Folate (Quatrefolic®), prominently featured.
Key moments from the Complementary Medicines Australia Innovation Day, featuring our essential ingredients, MenaQ7 as Vitamin K2 (MenaQ7®) and Active Folate (Quatrefolic®).
This event served as a significant platform for professionals in the industry to exchange ideas on various aspects such as manufacturing, formulation, ingredients, packaging, and innovation. Dr. Brad from CMG presented an insightful session on “Scientific and Evidence-Based Advancements in Enhancing Self-Care through Complementary Medicine,” showcasing the benefits of these essential nutrients.
MenaQ7® is essential for cardiovascular and bone health. It plays a crucial role in blood coagulation, aiding in the production of prothrombin and other coagulation factors. Moreover, Vitamin K2 helps prevent calcium deposition in blood vessel walls, reducing arterial stiffness. For bone health, it is involved in the production, activation, and carboxylation of osteocalcin, which is vital for calcium transport, homeostasis, and bone mineralization. Recent research also highlights its additional functions in energy metabolism, antioxidant properties, anti-inflammatory effects, immunomodulation, and brain signaling, showing potential benefits for conditions like rheumatoid arthritis, depression in women with PCOS, and Alzheimer’s disease.

Active Folate (Quatrefolic®) is the biologically active form of folate, known as 5-MTHF, and is crucial for numerous cellular processes. It is involved in one-carbon metabolism, methylation, amino acid metabolism, cell growth, DNA repair, and the re-methylation of homocysteine to methionine. Folate deficiency can lead to megaloblastic anemia, peripheral neuropathy, cardiovascular diseases, hyperhomocysteinemia, depression, and cognitive dysfunction. Quatrefolic® is especially beneficial for individuals with an MTHFR polymorphism, as it bypasses the need for conversion to the active form, ensuring optimal utilization by the body.

The CMA Innovation Day was a resounding success, providing an excellent platform for showcasing the advancements and benefits of our high-quality ingredients, Vitamin K2 (Menaquinone-7) and Active Folate (Quatrefolic®). We are proud to support the complementary medicine industry with our scientifically backed products that enhance self-care and overall wellness.

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.